Antihypertensive effects of flavonoids isolated from Brazilian green propolis in spontaneously hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 7, 2009, Pages 1244-1250

  Maruyama, Hiroe ^a   Sumitou, Yoshiki ^a   Sakamoto, Takashi ^a   Araki, Yoko ^a   Hara, Hideaki ^b  

^a Api Company Ltd   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antihypertensive effect; Brazilian green propolis; Flavonoid; Spontaneously hypertensive rat

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT; BETULETOL; DIHYDROKAEMPFERIDE; FLAVONOID; ISOSAKURANETIN; KAEMPFERIDE; PROPOLIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BACCHARIS; BACCHARIS DRACUNCULIFOLIA; BEE EXTRACT; BLOOD PRESSURE MEASUREMENT; BRAZIL; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; HYPERTENSION; NONHUMAN; RAT; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BACCHARIS; BLOOD PRESSURE; BRAZIL; FLAVONOIDS; HYPERTENSION; MALE; MOLECULAR STRUCTURE; PROPOLIS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATION;

EID: 67650725839     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1244     Document Type: Article

References (26)

1. Drago L., Mombelli B., De Vecchi E., Fassina M. C., Tocalli L., Gismondo M. R., J. Chemother., 12, 390-395 (2000).
2. Erratum in: J. Chemother., 13, 102 (2001).
3. Kujumgiev A., Tsvetkova I., Serkedjieva Y., Bankova V., Christov R., Popov S., J. Ethnopharmacol., 64, 235-240 (1999).
4. Wang L., Mineshita S., Ga I., Shigematsu T., Matsumoto T., Jpn. J. Clin. Pharmacol. Ther., 24, 223-224 (1993).
5. Scheller S., Krol W., Swiacik J., Owczarek S., Gabrys J., Shani J., Z. Naturforsch., 44, 1063-1065 (1989).
6. Grunberger D., Banerjee R., Eisinger K., Oltz E. M., Efros L., Caldwell M., Esterez V., Nakanishi K., Experientia, 44, 230-232 (1988).
7. Tokunaga K., Yoshida C., Suzuki K., Maruyama H., Futamura Y., Araki Y., Mishima S., Biol. Pharm. Bull., 27, 189-192 (2004).
8. Suzuki A., Kagawa D., Ochiai R., Tokimitsu I., Saito I., Hypertens. Res., 25, 99-107 (2002).
9. Lacy F., O'Connor D. T., Schmid-Schönbein G. W., J. Hypertens., 16, 291-303 (1998).
10. Kumar K. V., Das U. N., Free Radic. Res. Commun., 19, 59-66 (1993).
11. Jameson M., Dai F. X., Luscher T., Skopec J., Diederich A., Diederich D., Hypertension, 21, 280-288 (1993).
12. Kubota Y., Umegaki K., Kobayashi K., Tanaka N., Kagota S., Nakamura K., Kunitomo M., Shinozuka K., Clin. Exp. Pharmacol. Physiol., 31, S29-S30 (2004).
13. Mishima S., Yoshida C., Akino S., Sakamoto T., Biol. Pharm. Bull., 28, 1909-1914 (2005).
14. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., Zarzuelo A., Gen. Pharmacol., 24, 857-862 (1993).
15. Breitmair E., Voelter W., "Carbon-13 NMR Spectroscopy," VCH Verlagsgesellschaft, Weinheim, 1987, pp. 450-456.
16. Manez S., Paya M., Terenico C., Villar A., Planta Med., 54, 187-188 (1988).
17. Agrawal P. K., Rastogi R. P., Heterocycles, 16, 2181-2236 (1981).
18. Ramachandran Nair A. G., Sivakumar R., Phytochemistry, 29, 1011-1012 (1990).
19. Banskota A. H., Tezuka Y., Prasain J. K., Matsushige K., Saiki I., Kadota S., J. Nat. Prod., 61, 896-900 (1998).
20. He Z. W., Lu Z. P., Wu W. S., Zhu Y., Xibei Zhiwu Xuebao, 27, P1884-P1887 (2007).
21. Da Silva Filho A. A., de Sousa J. P., Soares S., Furtado N. A., Andrade e Silva M. L., Cunha W. R., Gregorio L. E., Nanayakkara N. P., Bastos J. K., Z. Naturforsch., 63, 40-46 (2008).
22. Morello S., Vellecco V., Alfieri A., Mascolo N., Cicala C., Life Sci., 78, 825-830 (2006).
23. Villar I. C., Jimenez R., Galisteo M., Garcia-Saura M. F., Zarzuelo A., Duarte J., Planta Med., 68, 847-850 (2002).
24. Kim S. J., Park H., Kim H. P., Arch. Pharm. Res., 27, 937-943 (2004).
25. Matsuda H., Morikawa T., Ando S., Toguchida I., Yoshikawa M., Bioorg. Med. Chem., 11, 1995-2000 (2003).
26. Jeong J. M., Choi C. H., Kang S. K., Lee I. H., Lee J. Y., Jung H., J. Pharm. Pharm. Sci., 10, 537-546 (2007).